Karuna Therapeutics Inc. (KRTX)
NASDAQ: KRTX
· Real-Time Price · USD
329.83
0.09 (0.03%)
At close: Mar 15, 2024, 9:00 PM
Karuna Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -433.68M | -396.07M | -353.91M | -315.69M | -276.34M | -228.08M | -202.05M | -171.53M | -143.81M | -139.85M | -107.76M | -90.39M |
Depreciation & Amortization | 1.7M | 1.56M | 1.39M | 1.19M | 1.11M | 1.04M | 859K | 642K | 506K | 318K | 255K | 236K |
Stock-Based Compensation | 74.6M | 64.47M | 58.19M | 52.32M | 47.45M | 43.11M | 39.29M | 34.63M | 29.81M | 25.96M | 21.9M | 17.66M |
Other Working Capital | 16.71M | 33.4M | 22.86M | 8.71M | 2.84M | 13.9M | 23.48M | 5.34M | 11.52M | -6.37M | -13.31M | -12.83M |
Other Non-Cash Items | -37.97M | 80.27M | 90.39M | -12.6M | -5.01M | 26K | 1.13M | 1.15M | 1.76M | 2.38M | 1.87M | 2.02M |
Deferred Income Tax | n/a | -112.51M | -112.51M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 9.53M | 8.77M | 12.99M | -4.06M | 4.77M | 27.66M | 20.67M | 5.61M | 10.85M | -5.62M | -12.05M | -12.22M |
Operating Cash Flow | -385.82M | -353.52M | -303.47M | -278.83M | -228.01M | -156.25M | -140.11M | -129.5M | -100.88M | -116.83M | -95.8M | -82.69M |
Capital Expenditures | -2.92M | -2.41M | -1.95M | -1.63M | -709K | -1.19M | -2.53M | -2.82M | -3.07M | -2.38M | -972K | -390K |
Cash Acquisitions | 223.87M | 225.93M | 546.72M | 293.91M | 293.07M | 295M | 3.15M | 3.15M | 3.21M | 485K | 485K | 485K |
Purchase of Investments | -1.52B | -1.77B | -1.77B | -1.2B | -930.28M | -570.68M | -300.89M | -368.28M | -400.83M | -369.74M | -402.42M | -354.72M |
Sales Maturities Of Investments | 1.36B | 1.21B | 888.5M | 572.6M | 344.8M | 250.27M | 223.47M | 315.31M | 381.21M | 421.12M | 435.92M | 326.98M |
Other Investing Acitivies | -223.87M | -225.93M | -546.72M | -299.02M | -298.38M | -300.31M | -8.46M | -3.35M | -3.21M | -485K | -485K | -485K |
Investing Cash Flow | -160.32M | -559.38M | -879.71M | -631.68M | -586.39M | -321.8M | -80.15M | -55.99M | -22.69M | 48.99M | 32.53M | -28.13M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 483.37M | 468.89M | 1.31B | 1.3B | 855.78M | 854.14M | 10.7M | 8.01M | 277.57M | 275.37M | 275.15M | 273.96M |
Financial Cash Flow | 483.37M | 468.89M | 1.31B | 1.3B | 855.78M | 854.14M | 10.7M | 8.01M | 277.57M | 275.37M | 275.15M | 273.96M |
Net Cash Flow | -62.77M | -444M | 127.25M | 386.46M | 41.38M | 376.1M | -209.55M | -177.48M | 154.01M | 207.54M | 211.88M | 163.14M |
Free Cash Flow | -388.74M | -355.93M | -305.42M | -280.46M | -228.72M | -157.44M | -142.64M | -132.32M | -103.95M | -119.21M | -96.77M | -83.08M |